Revenue Growth and Top-Line Performance
Q4 net sales of $468 million, up 6% year-over-year. Full-year revenue benefited from acquisitions (three closed in 2025 adding ~ $95 million of annualized revenue) and price/mix in some regions.
Adjusted EBITDA and Margin Improvement
Adjusted EBITDA of $72 million in Q4, an 11% increase year-over-year, with adjusted EBITDA margin improving to 15.3% (up 75 basis points YoY). Management expects continued YoY adjusted EBITDA growth in 2026.
Earnings Per Share Performance
Q4 non-GAAP diluted EPS of $1.65, a 24% increase year-over-year. Full-year non-GAAP diluted EPS of $7.02 after adjusting for non-GAAP items.
Asia Pacific Strength and Consistent Organic Growth
Asia Pacific net sales increased 15% in Q4 and 13% for the full year; organic volume growth in Asia Pacific was +4% in Q4 and +5% for the year — the 10th consecutive quarter of year-over-year volume growth in the region.
Net Share Gains and New Business Wins
Net share gains of approximately 4% in Q4 helped offset soft markets; the company reported new business wins across all regions and successful cross-selling initiatives.
Acquisition Contributions and Integration
Acquisitions contributed ~6% to Q4 sales (Dipsol contributed $21 million in Q4). Company completed three acquisitions in 2025 and expects continued disciplined M&A to expand TAM and capabilities.
Cost Savings and Structural Initiatives
Complexity and cost reduction plan generated roughly $25 million of run-rate savings for the full year; identified additional network and process optimization actions (e.g., Dortmund closure) expected to deliver incremental savings ($2 million in 2026, ~$5 million annually beginning 2027).
Balance Sheet and Capital Allocation
Net debt at year-end was $691 million with net leverage reduced to 2.3x trailing 12-month adjusted EBITDA. Returned $76 million to shareholders in 2025 (share repurchases $42 million; dividends $34 million) and continued investment in growth (full-year capex $56 million, China facility under construction).